Tanushree Kakani Acquires Convertible Warrants in Godavari Drugs Ltd.
Godavari Drugs Limited announced that Tanushree Kakani, a promoter of the company, acquired 1,38,000 convertible warrants through a preferential issue on March 18, 2026.According to a filing, prior to the acquisition, Kakani held 1,40,000 shares. The acquisition was made through preferential allotment.
The total share capital of Godavari Drugs Limited before the acquisition was Rs. 7,53,05,000, divided into 75,30,500 fully paid-up equity shares of Rs. 10 each. Following the acquisition, the equity share capital is Rs. 10,12,74,350 divided into 1,01,27,435 equity shares of Rs. 10 each.
Details of Acquisition:
The following table summarizes the changes in holdings:
| Detail | Before Acquisition | After Acquisition |
|---|---|---|
| Shares carrying voting rights | 1,40,000 | 1,40,000 |
| Warrants/convertible securities | - | 1,38,000 |
| Total (Shares + Warrants) | 1,40,000 | 2,78,000 |
Tanushree Kakani’s signature concluded the disclosure.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.